Giant Cell Myocarditis in Children
- PMID: 18978925
- PMCID: PMC2083637
- DOI: 10.1016/j.ppedcard.2007.08.002
Giant Cell Myocarditis in Children
Abstract
Giant cell myocarditis is a rare cause of heart failure and arrhythmias in children. In the multicenter GCM registry, 4 of 63 cases (6%) occurred in subjects less than age 19. In this manuscript, these 4 cases are summarized and the findings related to other published reports. Unlike pediatric lymphocytic myocarditis, that generally has a good prognosis despite a fulminant clinical course, GCM usually results in death or heart transplantation. In children as in adults, GCM can often be distinguished clinically by a failure to respond to usual care and the frequent occurrence of ventricular arrhythmias or heart block in the setting of acute cardiomyopathy. GCM is also associated with other immune-mediated disorders in about 20% of patients. In children associated immune-mediated disorders have only been observed in females. Prompt endomyocardial biopsy in the setting of suspected GCM can affect choice of mechanical circulatory support (MCS), lead to early listing for cardiac transplantation, and consideration of cyclosporine-based immunosuppression.
References
-
- Goldberg GM. Myocarditis of the Giant-Cell Type in an Infant. Am J Clin Pathol. 1955;25:510–513. - PubMed
-
- Das B, et al. Cardiac Transplantation for Pediatric Giant Cell Myocarditis. J Heart Lung Transplant. 2006;25(4):474–478. - PubMed
-
- Cooper LT, Berry GJ, Shabetai R. Giant Cell Myocarditis: Natural History and Treatment. N Engl J Med. 1997;336:1860–66. - PubMed
-
- Daubeney P, et al. Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study. Circ. 2006;114(24):2671–8. - PubMed
-
- Towbin J, et al. Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in Children. JAMA. 2006;296(15):1867–76. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources